Intravenous Tranexamic Acid Decreases Blood Transfusion in Off-Pump Coronary Artery Bypass Surgery: A Meta-analysis
DOI:
https://doi.org/10.1532/hsf.2797Abstract
Background: Tranexamic acid (TXA) has been widely used during on-pump coronary artery bypass graft (CABG) surgery owing to its antifibrinolytic effect. However, the efficacy and safety of TXA in off-pump CABG surgery remains unconfirmed, especially intravenous (IV) administration.
Objective: The aim of this study was to evaluate the effectiveness and safety of IV administration of TXA in off-pump CABG settings.
Methods and Results: A comprehensive literature search was performed to identify randomized controlled trials (RCTs) that compared IV use of TXA with placebo in the reduction of postoperative 24-hour blood transfusion, as well as postoperative death and thrombotic events. The combined estimations were compiled with a fixed-effects model or, if heterogeneity existed, a random-effects model. Funnel plots and Egger’s test were used to assess potential publication bias. Subgroup analyses were used to explore possible sources of heterogeneity. In total, 12 RCTs met the inclusion criteria. IV administration of TXA significantly reduced the risk of packed red blood cell (PRBC) transfusion [risk ratio (RR) = 0.61, 95% confidence interval (CI) 0.503 to 0.756, P < .001, I2 = 0.0%) during the 24 hours after surgery. However, there was no statistical significance in platelet (RR = 0.613, 95% CI 0.112 to 3.348, P = .572, I2 = 0.0%) or total fresh frozen plasma (FFP) (RR = 0.511, 95% CI 0.246 to 1.063, P = .073, I2 = 0.0%) transfusion. Also, no significant difference was found in major adverse events (death or thrombotic complications) (RR = 0.917, 95% CI 0.532 to 1.581, P = .756, I2 = 0.0%) between the 2 groups. Interestingly, further subgroup analysis demonstrated that IV TXA decreased the risk of prothrombin time (PT)- and international normalized ratio (INR)-guided FFP transfusion (RR = 0.462, 95% CI 0.296 to 0.721,
P = .001, I2 = 0.0%).
Conclusion: IV TXA was effective in reducing allogeneic blood component transfusion (PRBCs and PT- or INR-guided FFP transfusion), without increasing the incidence of postoperative death or thrombotic complications in off-pump CAB surgery.
References
Adler MSC, Brindle W, Burton G, et al. 2011. Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: A systematic review and meta-analysis. J Cardiothorac Vasc Anesth 25:26-35.
Ahn SW, Shim JK, Youn YN, et al. 2012. Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery. Circ J 76:96-101.
Al-Ruzzeh S, Ambler G, Asimakopoulos G, et al. 2003. Off-pump coronary artery bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: A United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome. Circulation 108 (suppl 1):I1-I8.
Andreasen JJ, Nielsen C. 2004. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. Eur J Cardiothorac Surg 26:311-7.
Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-101.
Casati V, Della VP, Benussi S, et al. 2004. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg 128:83-91.
Casati V, Gerli C, Franco A, et al. 2001. Activation of coagulation and fibrinolysis during coronary surgery: On-pump versus off-pump techniques. Anesthesiology 95:1103-9.
Casati V, Gerli C, Franco A, et al. 2001. Tranexamic acid in off-pump coronary surgery: A preliminary, randomized, double-blind, placebo-controlled study. Ann Thorac Surg 72:470-5.
Chakravarthy M, Muniraj G, Patil S, Suryaprakash S, Mitra S, Shivalingappa B. 2012. A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130/0.4) undergoing off pump coronary artery bypass surgery. Ann Card Anaesth 15:105-10.
Dai Z, Chu H, Wang S, Liang Y. 2018. The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: A systematic review and cumulative meta-analysis. J Clin Anesth 44:23-31.
Deeks JJ, Higgins JPT, Altman DG. 2008. Analysing data and undertaking meta-analyse. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons.
Egger M, Davey SG, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-34.
Faraoni D, Rahe C, Cybulski KA. 2018. Use of antifibrinolytics in pediatric cardiac surgery: Where are we now? Paediatr Anaesth 29:435-40.
Higgins JP, Altman DG, Gotzsche PC, et al. 2011. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928.
Higgins JPT, Altman DG. 2008. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Oxford: Wiley; 187-241.
Jares M, Vanek T, Straka Z, Brucek P. 2003. Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. J Cardiovasc Surg (Torino) 44:205-8.
Knapik P, Knapik M, Zembala MO, et al. 2019. In-hospital and mid-term outcomes in patients reoperated on due to bleeding following coronary artery surgery (from the KROK Registry). Interact Cardiovasc Thorac Surg, In press.
Kurlansky PA. 2003. Is there a hypercoagulable state after off-pump coronary artery bypass surgery? What do we know and what can we do? J Thorac Cardiovasc Surg 126:7-10.
Laupacis A, Fergusson D. 1997. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg 85:1258-67.
Mavridis D, Salanti G. 2014. How to assess publication bias: Funnel plot, trim-and-fill method and selection models. Evid Based Ment Health 17:30.
Mehr-Aein A, Sadeghi M, Madani-civi M. 2007. Does tranexamic acid reduce blood loss in off-pump coronary artery bypass? Asian Cardiovasc Thorac Ann 15:285-9.
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. 1999. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354:1896-900.
Murphy GJ, Mango E, Lucchetti V, et al. 2006. A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 132:475-81.
Myles PS, Smith JA, Forbes A, et al. 2017. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 376:136-48.
Schulz KF, Grimes DA. 2005. Sample size calculations in randomised trials: Mandatory and mystical. Lancet 365:1348-53.
Shi J, Wang G, Lv H, Yuan S, Wang Y, Ji H, Li L. 2013. Tranexamic acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: Randomized trial and 1-year follow-up. Ann Thorac Surg 95:795-802.
Taghaddomi RJ, Mirzaee A, Attar AS, Shirdel A. 2009. Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth 23:312-5.
Trevisan D, Zavatti L, Gabbieri D, Pedulli M, Giordano G, Meli M. 2016. Point-of-care-based protocol with first-line therapy with coagulation factor concentrates is associated with decrease allogenic blood transfusion and costs in cardiovascular surgery: An Italian single-center experience. Minerva Anestesiol 82:1077-88.
Vanek T, Jares M, Fajt R, et al. 2005. Fibrinolytic inhibitors in off-pump coronary surgery: A prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). Eur J Cardiothorac Surg 28:563-8.
Velioglu Y, Isik M. 2019. Early-term outcomes of off-pump versus on-pump beating-heart coronary artery bypass surgery. Thorac Cardiovasc Surg 67:546-53.
Wang G, Xie G, Jiang T, et al. 2012. Tranexamic acid reduces blood loss after off-pump coronary surgery: A prospective, randomized, double-blind, placebo-controlled study. Anesth Analg 115:239-43.
Wei M, Jian K, Guo Z, et al. 2006. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting. Scand Cardiovasc J 40:105-9.
Xu S, Chen JY, Zheng Q, et al. 2019. The safest and most efficacious route of tranexamic acid administration in total jointarthroplasty: A systematic review and network meta-analysis. Thromb Res 176:61-6.
Zhang Y, Gao X, Yuan S, et al. 2018. Effects of tranexamic acid on short-term and long-term outcomes of on-pump coronary artery bypass grafting: Randomized trial and 7-year follow-up. Cardiovasc Ther 36:e12472.
Zhou ZF, Zhang FJ, Huo YF, et al. 2017. Intraoperative tranexamic acid is associated with postoperative stroke in patients undergoing cardiac surgery. PLoS One 12:e177011.
Zhou ZF, Jia XP, Sun K, et al. 2017. Mild volume acute normovolemichemodilution is associated with lower intraoperative transfusion and postoperative pulmonary infection in patients undergoing cardiac surgery—A retrospective, propensity matching study. BMC Anesthesiol 17:13.
